• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.08%

    Acorda Therapeutics, Inc. (ACOR)

    -NasdaqGS
    32.08 Down 0.01(0.03%) Jul 2, 4:00PM EDT
    Add to Portfolio
    Prev Close:32.09
    Open:32.00
    Bid:N/A
    Ask:45.00 x 100
    1y Target Est:43.78
    Beta:1.14
    Next Earnings Date:30-Jul-15ACOR Earnings announcement
    Day's Range:31.60 - 32.20
    52wk Range:28.26 - 45.45
    Volume:359,339
    Avg Vol (3m):622,125
    Market Cap:1.37B
    P/E (ttm):96.92
    EPS (ttm):0.33
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ACOR

    Comparison

    Symbol% ChgMkt Cap
    ACORDown 0.03%1.37B
    BIIBDown 0.28%95.10B
    TEVAUp 1.00%52.20B

    Key Statistics

    Forward P/E (1 yr):34.49
    P/S (ttm):3.26
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :0.58
    Quarterly EPS Est (Jun-15) :0.17
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):1.49

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Acorda Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and commercializes novel therapies for neurological disorders in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback